Trends in incidence of total or type 2 diabetes: systematic reviewDianna J. Magliano(Baker Heart and Diabetes Institute), Jonathan E. Shaw(Baker Heart and Diabetes Institute)BMJSeptember 11, 201910.1136/bmj.l5003Cited by 347SaveCiteExport RISWatch citationsRelated PapersRisk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study|The Lancet Diabetes & Endocrinology|2020|93